Feeds

Final drug trial victim out of the woods

As placebo man balks at follow-ups

Intelligent flash storage arrays

All of the volunteers given an experimental immune drug in a London trial have now made it off the critical list at Northwick Park hospital.

The last of six men given biotech firm TeGenero's TGN1412 compound is now fully conscious and looks set to make a full recovery.

Intensive care clinical director Dr Ganesh Suntharalingam said: "We are delighted that the six patients have come through safely from the most critical stage of their condition."

He praised intensive care staff for how they dealt with the victims' very serious condition when they were transferred there from a private testing unit more than three weeks ago.

TeGenero said today its preliminary investigations showed it had followed all correct procedures in the animal testing phase of the drug. It also says the problem was unforseeable based on preclinical results (see here for why many think the problems might have been foreseeable though).

Watchdog the Medicines and Healthcare products Regulatory Agency (MHRA) agreed, saying it hasn't been able find a problem with how the trial was carried out.

It also couldn't find evidence of contamination of the drug. Some had speculated bacterial toxins might be responsible for the multiple organ failure.

MRHA added that its findings are not yet conclusive, but that the suspected flaws in the action of the drug itself were the most likely cause. The Secretary of State for Health is assembling a panel of experts to investigate why the animal trials didn't pick up the near-deadly complications.

Meanwhile, Raste Khan, 23, one of the men given a harmless placebo, appeared in The Sun today, saying he was still traumatised by what he saw during the trials. "I still feel haunted by it and I know my family have been extremely upset. I am too frightened even to get sleeping pills from the doctor."

He claims test contractor Parexel is demanding he honour the terms of his contract by attending follow-ups in order to pocket his £2,000 volunteer fee.

Testing contractor Parexel was unavailable for comment. ®

Providing a secure and efficient Helpdesk

More from The Register

next story
GRAV WAVE DRAMA: 'Big Bang echo' may have been grit on the scanner – boffins
Exit Planet Dust on faster-than-light expansion of universe
SpaceX Dragon cargo truck flies 3D printer to ISS: Clawdown in 3, 2...
Craft berths at space station with supplies, experiments, toys
That glass of water you just drank? It was OLDER than the SUN
One MEELLION years older. Some of it anyway
NASA rover Curiosity drills HOLE in MARS 'GOLF COURSE'
Joins 'traffic light' and perfect stony sphere on the Red Planet
Big dinosaur wowed females with its ENORMOUS HOOTER
That's right, Doris, I've got biggest snout in the prehistoric world
Japanese volcano eruption reportedly leaves 31 people presumed dead
Hopes fade of finding survivors on Mount Ontake
Relive the death of Earth over and over again in Extinction Game
Apocalypse now, and tomorrow, and the next day, and the day after that ...
prev story

Whitepapers

A strategic approach to identity relationship management
ForgeRock commissioned Forrester to evaluate companies’ IAM practices and requirements when it comes to customer-facing scenarios versus employee-facing ones.
Storage capacity and performance optimization at Mizuno USA
Mizuno USA turn to Tegile storage technology to solve both their SAN and backup issues.
High Performance for All
While HPC is not new, it has traditionally been seen as a specialist area – is it now geared up to meet more mainstream requirements?
Beginner's guide to SSL certificates
De-mystify the technology involved and give you the information you need to make the best decision when considering your online security options.
Security for virtualized datacentres
Legacy security solutions are inefficient due to the architectural differences between physical and virtual environments.